Sensydia
Non-invasive cardiac assessment without catheterization
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Sensydia is a Los Angeles medical technology company developing the Cardiac Performance System (CPS), a non-invasive, automated platform that uses disposable sensors to measure key hemodynamic metrics such as ejection fraction, cardiac output and pulmonary artery pressure at the bedside, in the ICU/ER or in cardiology offices, without invasive catheterization. On 13 October 2026 it announced an initial closing of more than $6 million in new financing led by Colle Capital Partners with participation from Orlando Health Ventures, to carry CPS through its ACOUSTIC-1 study toward FDA authorization and prepare for commercial launch. Anthony Arnold is CEO.
- Website
- sensydia.com
- Location
- Los Angeles, CA, USA
- Added via
- web
- Ownership
- unclaimed